Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Amin H. Nassar(Brigham and Women's Hospital), Elio Adib(Brigham and Women's Hospital), Sarah Abou Alaiwi(Brigham and Women's Hospital), Talal El Zarif(Dana-Farber Cancer Institute), Stefan Groha(Dana-Farber Cancer Institute), Elie W. Akl(Brigham and Women's Hospital), Pier Vitale Nuzzo(Dana-Farber Cancer Institute), Tarek H. Mouhieddine(Icahn School of Medicine at Mount Sinai), Tomin Perea-Chamblee(Memorial Sloan Kettering Cancer Center), Kodi Taraszka(University of California, Los Angeles), Habib El‐Khoury(Dana-Farber Cancer Institute), Muhieddine Labban(Brigham and Women's Hospital), Christopher J. Fong(Memorial Sloan Kettering Cancer Center), Kanika Arora(Memorial Sloan Kettering Cancer Center), Chris Labaki(Dana-Farber Cancer Institute), Wenxin Xu(Dana-Farber Cancer Institute), Guru Sonpavde(Dana-Farber Cancer Institute), Robert I. Haddad(Dana-Farber Cancer Institute), Kent W. Mouw(Dana-Farber Cancer Institute), Marios Giannakis(Dana-Farber Cancer Institute), F. Stephen Hodi(Dana-Farber Cancer Institute), Noah Zaitlen(University of California, Los Angeles), Adam J. Schoenfeld(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Laura E. MacConaill(Brigham and Women's Hospital), Guruprasad Ananda(Dana-Farber Cancer Institute), David J. Kwiatkowski(Brigham and Women's Hospital), Toni K. Choueiri(Dana-Farber Cancer Institute), Deborah Schrag(Memorial Sloan Kettering Cancer Center), Jian Carrot‐Zhang(Memorial Sloan Kettering Cancer Center), Alexander Gusev(Brigham and Women's Hospital)
Cited by 115Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis